Enhancement of sparc (osteonectin) synthesis in arthritic cartilage: Increased levels in synovial fluids from patients with rheumatoid arthritis and regulation by growth factors and cytokines in chondrocyte cultures
Open Access
- 1 April 1996
- journal article
- basic science
- Published by Wiley in Arthritis & Rheumatism
- Vol. 39 (4), 539-551
- https://doi.org/10.1002/art.1780390402
Abstract
Objective. To investigate the roles of SPARC (secreted protein, acidic and rich in cysteine) (osteonectin) in arthritis, using cartilage and synovium specimens and synovial fluids (SF) from patients with rheumatoid arthritis (RA) or osteoarthritis (OA), and to examine the effects of cytokines, growth factors, and hormones on SPARC synthesis by chondrocytes in culture. Methods. SPARC in cartilage and synovium was immunostained with monoclonal antibodies. SPARC synthesis by cultured chondrocytes was measured by Northern blot analysis, immunoblotting, and sandwich enzyme‐linked immunosorbent assay. Results. SPARC was identified in numerous chondrocytes in the superficial and middle zones and in regenerating chondrocytes of RA and OA joints, whereas such staining was absent in these zones of normal cartilage, except for weak signals from a few chondrocytes in the deep zone. In addition, SPARC synthesis was enhanced in synovial cells of RA and OA joints. The average SPARC level in SF was 10‐fold higher in the RA than in the OA population. In rabbit articular chondrocyte cultures, administration of transforming growth factor β1 (TGFβ1) and bone morphogenetic protein 2 increased SPARC levels at 24–48 hours, whereas interleukin‐1β (IL‐1β), IL‐1α, tumor necrosis factor α, lipopolysaccharide, phorbol myristate acetate, basic fibroblast growth factor, and dexamethasone decreased SPARC levels at 24–72 hours. TGFβ increased SPARC messenger RNA (mRNA) levels at 24 hours, whereas IL‐1β caused a marked decrease in SPARC mRNA levels at 24 hours. Furthermore, IL‐1 decreased the glycosylation of SPARC. Conclusion. These findings suggest that various growth factors and cytokines, including TGFβ1 and IL‐1β, regulate the production of SPARC by chondrocytes at pre‐ and posttranslational levels, and that SPARC synthesis is markedly enhanced in arthritic joints.Keywords
This publication has 47 references indexed in Scilit:
- Osteonectin/SPARC Regulates Cellular Secretion Rates of Fibronectin and Laminin Extracellular Matrix ProteinsBiochemical and Biophysical Research Communications, 1994
- Osteonectin/SPARC is a product of articular chondrocytes/cartilage and is regulated by cytokines and growth factorsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
- IL-1β-induced expression of PDGF-AA isoform in rabbit articular chondrocytes is modulated by TGF-β1Experimental Cell Research, 1991
- Stimulation of cartilage‐matrix proteoglycan synthesis by morphologically transformed chondrocytes grown in the presence of fibroblast growth factor and transforming growth factor‐betaJournal of Cellular Physiology, 1989
- Effect of transforming growth factor β on cell proliferation and glycosaminoglycan synthesis by rabbit growth-plate chondrocytes in cultureBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1988
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Radioimmunoassay for osteonectin. Concentrations in bone, nonmineralized tissues, and bloodJournal of Bone and Mineral Research, 1987
- Human recombinant interleukin 1-mediated suppression of glycosaminoglycan synthesis in cultured rat costal chondrocytesBiochemical and Biophysical Research Communications, 1986
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979